| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Gerald W Dorn | |
| P2860 | cites work | Detection of microRNA expression in human peripheral blood microvesicles | Q21144210 |
| Myosin heavy chain gene expression in human heart failure | Q24561412 | ||
| miR-126 regulates angiogenic signaling and vascular integrity | Q24569770 | ||
| Circulating microRNAs are new and sensitive biomarkers of myocardial infarction | Q24606701 | ||
| AngiomiRs--key regulators of angiogenesis | Q24645570 | ||
| Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps | Q24645826 | ||
| Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure | Q24648103 | ||
| MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction | Q24648242 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| The impact of microRNAs on protein output | Q24653549 | ||
| The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis | Q24656947 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure | Q24673535 | ||
| The functions of animal microRNAs | Q27860621 | ||
| MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice | Q28115423 | ||
| Myosin heavy chain isoform expression in the failing and nonfailing human heart | Q28145777 | ||
| Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response | Q28273666 | ||
| A translational study of circulating cell-free microRNA-1 in acute myocardial infarction | Q28275588 | ||
| Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 | Q28295844 | ||
| miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling | Q28304542 | ||
| MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand | Q28509297 | ||
| MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
| Dicer is essential for mouse development | Q28511142 | ||
| Control of stress-dependent cardiac growth and gene expression by a microRNA | Q28587851 | ||
| Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis | Q29547607 | ||
| MicroRNA-133 controls cardiac hypertrophy | Q29616572 | ||
| A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance | Q29619547 | ||
| MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure | Q29619548 | ||
| Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
| MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis | Q30495845 | ||
| MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts | Q33580704 | ||
| Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure | Q33689545 | ||
| microRNAs in heart disease: putative novel therapeutic targets? | Q33728265 | ||
| Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping | Q33769212 | ||
| Control of cardiac myosin heavy chain gene expression | Q34040340 | ||
| MicroRNA regulatory networks in cardiovascular development | Q34070117 | ||
| Gene expression profiling in whole blood of patients with coronary artery disease | Q34070557 | ||
| Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy | Q34113952 | ||
| Evolutionary implications of three novel members of the human sarcomeric myosin heavy chain gene family. | Q34120879 | ||
| Evolution of sarcomeric myosin heavy chain genes: evidence from fish | Q34304851 | ||
| A biochemical approach to identifying microRNA targets | Q36288545 | ||
| Early nonsense: mRNA decay solves a translational problem | Q36488710 | ||
| The fuzzy logic of physiological cardiac hypertrophy | Q36772114 | ||
| MicroRNAs repress translation of m7Gppp-capped target mRNAs in vitro by inhibiting initiation and promoting deadenylation | Q36910688 | ||
| Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. | Q37358790 | ||
| Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks | Q37448085 | ||
| MicroRNAs and cardiac pathology | Q37478072 | ||
| miR-21 as a key regulator of oncogenic processes | Q37554678 | ||
| microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart | Q40036277 | ||
| Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans | Q41412919 | ||
| miRNA expression in the failing human heart: functional correlates | Q43124379 | ||
| Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling | Q43557501 | ||
| Mixed messages: transcription patterns in failing and recovering human myocardium. | Q51539355 | ||
| Circulating microRNAs in patients with coronary artery disease. | Q54421687 | ||
| MiR423-5p as a circulating biomarker for heart failure. | Q54439825 | ||
| MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients | Q61387983 | ||
| Altered microRNA expression in human heart disease | Q80825508 | ||
| Plasma microRNA 499 as a biomarker of acute myocardial infarction | Q84068842 | ||
| MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p | Q84218089 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart disease | Q190805 |
| microRNA | Q310899 | ||
| P304 | page(s) | 589-595 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Journal of Cardiovascular Pharmacology | Q2125808 |
| P1476 | title | MicroRNAs: redefining mechanisms in cardiac disease | |
| P478 | volume | 56 |
| Q36091480 | A H(a)rd Way to Adapt in Cardiac Hypertrophy |
| Q35804603 | Decoding the cardiac message: the 2011 Thomas W. Smith Memorial Lecture |
| Q36700827 | Differential membrane type 1 matrix metalloproteinase substrate processing with ischemia-reperfusion: relationship to interstitial microRNA dynamics and myocardial function |
| Q27027950 | Methodological challenges in utilizing miRNAs as circulating biomarkers |
| Q35763090 | MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction |
| Q90461158 | MicroRNAs in Cancer Treatment-Induced Cardiotoxicity |
| Q34760006 | MicroRNAs in cardiac disease |
| Q37162692 | Regulation of cardiac microRNAs by cardiac microRNAs |
| Q34485522 | Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology. |
Search more.